Verily Stock
Verily develops tools and devices to collect, organize and activate health data.
Sign up today and learn more about Verily Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Verily Stock
Verily aspires to create a world in which technology and life sciences are not distinct, but partners with a united mission. Formerly Google Life Sciences, Verily's mission is to bring together technology and life sciences to uncover new truths about health and disease. Verily's multidisciplinary teams have access to advanced research tools, large-scale computing power, and unique technical expertise. They work with partners from across the industry and many fields of research to develop new technology, launch studies, and start companies.
Funding History
| January 2017 | $800M |
|---|---|
| January 2019 | $1.0B |
Management
Product Manager
Collin Walter
Head of Engineering
Linus Upson
CEO
Andy Conrad
CFO
Duncan Welstead
Chief Medical Officer & C0-Founder
Jessica Mega
Head of People Operations
Sheela Krothapalli
Chief Technical Officer
Brian Otis
CFO
Deepak Ahuja
Head of Talent Acquisition
Kelly Gutilla
Chief Operating Officer
Ashraf Hanna
Press
businessinsider - Mar, 23 2024
Alphabet's Verily lays off employees working in one of its science groupsmobihealthnews - Mar, 23 2024
Q&A: Verily on using generative AI within healthcarepymnts - Feb, 25 2024
VC Firm S32 Names Verily Founder Andy Conrad General Partnerbusinesswire - Feb, 15 2024
Myoung Cha Joins Verily as Chief Product Officerbloomberg - Feb, 6 2024
Alphabet’s Verily Hires Health Veteran as Chief Product OfficerEquityZen Recognized As:
